Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Week in Review

Summaries of each week's events in China biotech are provided free to all readers.  A weekly email newsletter providing direct links to these articles is also available - click here for free email newsletter...

Week in Review: Inventis Closes $70 Million Financing to Develop 30 Novel Therapeutics

Week in Review: Grifols Pays $1.9 Billion for 26% Stake in Shanghai RAAS

Week in Review: Nanjing's NJCTTQ Agrees to $4 Billion Package for Abpro Bi-Specific Immunotherapies

Week in Review: Sciwind, a Hangzhou Biopharma, Raises $29.5 Million for NASH Treatments

Week in Review: CStone's Hong Kong IPO to Raise $304 Million at $1.5 Billion Valuation Next Week

Upcoming event
Shanghai , China
May 8-9, 2019
Take advanage of the early bird discount before March 31, 2019.
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event

Shanghai , China
March 26-28, 2019